ApicHope: Fucanglin granules approved for clinical trials
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, ApicHope announced that its wholly-owned subsidiary Guangzhou ApicHope Pharmaceutical Co., Ltd. (abbreviated as: ApicHope Pharmaceutical) has recently received the drug clinical trial approval notice issued by the National Medical Products Administration, allowing the product to conduct clinical trials for adults with Qi deficiency cold
According to the Zhitong Finance APP, ApicHope (300723.SZ) announced that its wholly-owned subsidiary Guangzhou ApicHope Pharmaceutical Co., Ltd. (referred to as: ApicHope Pharmaceutical) has recently received the clinical trial approval notice issued by the National Medical Products Administration, allowing the product to conduct clinical trials for adults with Qi deficiency cold